bioMerieux (GB:0RUG)
LSE:0RUG
Holding GB:0RUG?
Track your performance easily

bioMerieux (0RUG) Financial Statements

2 Followers

bioMerieux Financial Overview

bioMerieux's market cap is currently ―. The company's EPS TTM is €3.484; its P/E ratio is 29.34; and it has a dividend yield of 0.83%. bioMerieux is scheduled to report earnings on March 7, 2025, and the estimated EPS forecast is €1.91. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 552.60M€ 524.20M€ 803.50M€ 493.20M€ 389.20M
Total Assets€ 5.19B€ 5.04B€ 4.61B€ 4.16B€ 3.93B
Total Debt€ 505.40M€ 591.70M€ 462.50M€ 524.70M€ 481.30M
Net Debt€ -47.20M€ 67.50M€ -341.00M€ 31.50M€ 92.10M
Total Liabilities-----
Stockholders Equity€ 3.60B€ 3.47B€ 3.11B€ 2.70B€ 2.43B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in EUR

bioMerieux Earnings and Revenue History

bioMerieux Debt to Assets

bioMerieux Cash Flow

bioMerieux Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis